Related references
Note: Only part of the references are listed.Advances in oral peptide therapeutics
Daniel J. Drucker
NATURE REVIEWS DRUG DISCOVERY (2020)
Actively Targeted and Redox Responsive Delivery of Anticancer Drug by Chitosan Nanoparticles
Elisabetta Mazzotta et al.
PHARMACEUTICS (2020)
Sex differences in the risk of vascular disease associated with diabetes
Rianneke de Ritter et al.
BIOLOGY OF SEX DIFFERENCES (2020)
Intelligent Escape System for the Oral Delivery of Liraglutide: A Perfect Match for Gastrointestinal Barriers
Miaomiao Yin et al.
MOLECULAR PHARMACEUTICS (2020)
Preparation and evaluation of carboxymethyl chitosan-rhein polymeric micelles with synergistic antitumor effect for oral delivery of paclitaxel
Xiaoying Wang et al.
CARBOHYDRATE POLYMERS (2019)
Development of mutlifunctional nanoparticles self-assembled from trimethyl chitosan and fucoidan for enhanced oral delivery of insulin
Li-Chu Tsai et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Atypical forms of diabetes mellitus in Africans and other non-European ethnic populations in low- and middle-income countries: a systematic literature review
Charlotte Bavuma et al.
JOURNAL OF GLOBAL HEALTH (2019)
Prevalence and coprevalence of chronic comorbid conditions in patients with type 2 diabetes in Catalonia: a population-based cross-sectional study
Manel Mata-Cases et al.
BMJ OPEN (2019)
Orally Administered Semaglutide Versus GLP-1 RAs in Patients with Type 2 Diabetes Previously Receiving 1-2 Oral Antidiabetics: Systematic Review and Network Meta-Analysis
Solomon Nuhoho et al.
DIABETES THERAPY (2019)
Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption
Yina Song et al.
MOLECULAR PHARMACEUTICS (2019)
HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment
Emma S Scott et al.
BMJ Open (2019)
Analysis of the protective mechanism of liraglutide on retinopathy based on diabetic mouse model
Lingling Wu et al.
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2019)
Development and characterization of lipid-polymeric nanoparticles for oral insulin delivery
Debora Sgorla et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
Immunoprotective effects of a hemin-binding peptide derived from hemagglutinin-2 against infection with Porphyromonas gingivalis
Y. C. Zhu et al.
MOLECULAR ORAL MICROBIOLOGY (2018)
Novel Solid Lipid Nanoparticle with Endosomal Escape Function for Oral Delivery of Insulin
Yining Xu et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Liraglutide Modulates Appetite and Body Weight Through Glucagon-Like Peptide 1 Receptor-Expressing Glutamatergic Neurons
Jessica M. Adams et al.
DIABETES (2018)
Binding of HSA to Macromolecular ρHPMA Based Nanoparticles for Drug Delivery: An Investigation Using Fluorescence Methods
Xiaohan Zhang et al.
LANGMUIR (2018)
Ionic liquids for oral insulin delivery
Amrita Banerjee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Nanoparticulate-based drug delivery systems for small molecule anti-diabetic drugs: An emerging paradigm for effective therapy
Siddharth Uppal et al.
ACTA BIOMATERIALIA (2018)
Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist
Stephen T. Buckley et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Safety and efficacy of insulin degludec/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin-naive people with Type 2 diabetes: the DUAL IV trial
H. W. Rodbard et al.
DIABETIC MEDICINE (2017)
Mechanism of surface charge triggered intestinal epithelial tight junction opening upon chitosan nanoparticles for insulin oral delivery
Juan Wang et al.
CARBOHYDRATE POLYMERS (2017)
Dextran-b-poly(lactide-co-glycolide) polymersome for oral delivery of insulin: In vitro and in vivo evaluation
Mona Alibolandi et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Goblet cell targeting nanoparticle containing drug-loaded micelle cores for oral delivery of insulin
Peiwen Zhang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
The Glucose-Lowering Potential of Exenatide Delivered Orally via Goblet Cell- Targeting Nanoparticles
Xiang Li et al.
PHARMACEUTICAL RESEARCH (2015)
Optimized self-nanoemulsifying drug delivery system of atazanavir with enhanced oral bioavailability: in vitro/in vivo characterization
Gurinder Singh et al.
EXPERT OPINION ON DRUG DELIVERY (2014)
Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles
Xiuying Li et al.
BIOMATERIALS (2013)
Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption
Suha Attili-Qadri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Identification of a peptide sequence that improves transport of macromolecules across the intestinal mucosal barrier targeting goblet cells
Sang Kee Kang et al.
JOURNAL OF BIOTECHNOLOGY (2008)
Direct, controlled synthesis of the nonimmunogenic, hydrophilic polymer, poly(N-(2-hydroxypropyl)methacrylamide) via RAFT in aqueous media
CW Scales et al.
BIOMACROMOLECULES (2005)
Share Paper
